These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 24690513)

  • 21. It's not too late: the onset of the frontocentral P3 indexes successful response inhibition in the stop-signal paradigm.
    Wessel JR; Aron AR
    Psychophysiology; 2015 Apr; 52(4):472-80. PubMed ID: 25348645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention.
    Knott VJ; Millar AM; McIntosh JF; Shah DK; Fisher DJ; Blais CM; Ilivitsky V; Horn E
    Biol Psychol; 2011 Sep; 88(1):83-93. PubMed ID: 21742012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of stop-signal probability in the stop-signal paradigm: the N2/P3 complex further validated.
    Ramautar JR; Kok A; Ridderinkhof KR
    Brain Cogn; 2004 Nov; 56(2):234-52. PubMed ID: 15518938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of attenuating noradrenergic neurotransmission by clonidine on brain activity measures of visuospatial attention.
    Logemann HN; Böcker KB; Deschamps PK; Kemner C; Kenemans JL
    Hum Psychopharmacol; 2014 Jan; 29(1):46-54. PubMed ID: 24222260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological activity underlying inhibitory control processes in normal adults.
    Schmajuk M; Liotti M; Busse L; Woldorff MG
    Neuropsychologia; 2006; 44(3):384-95. PubMed ID: 16095637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay of neuronal processes during response inhibition: results from a combined event-related potentials (ERPs)/transcranial magnetic stimulation (TMS) study on methylphenidate.
    Hoegl T; Heinrich H; Albrecht B; Diruf M; Moll GH; Kratz O
    Int J Psychophysiol; 2011 Aug; 81(2):99-106. PubMed ID: 21620906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine Stroop and addiction memory--an ERP study.
    Fehr T; Wiedenmann P; Herrmann M
    Int J Psychophysiol; 2006 Nov; 62(2):224-32. PubMed ID: 16492391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors.
    Knott VJ; Fisher DJ; Millar AM
    Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity.
    Ettinger U; Williams SC; Patel D; Michel TM; Nwaigwe A; Caceres A; Mehta MA; Anilkumar AP; Kumari V
    Neuroimage; 2009 Apr; 45(2):549-61. PubMed ID: 19159693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Light up and see: enhancement of the visual mismatch negativity (vMMN) by nicotine.
    Fisher DJ; Scott TL; Shah DK; Prise S; Thompson M; Knott VJ
    Brain Res; 2010 Feb; 1313():162-71. PubMed ID: 20006592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.
    Erhardt S; Schwieler L; Engberg G
    Synapse; 2002 Mar; 43(4):227-37. PubMed ID: 11835517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-trial EEG power and phase dynamics associated with voluntary response inhibition.
    Yamanaka K; Yamamoto Y
    J Cogn Neurosci; 2010 Apr; 22(4):714-27. PubMed ID: 19413474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stop-signal response inhibition in schizophrenia: behavioural, event-related potential and functional neuroimaging data.
    Hughes ME; Fulham WR; Johnston PJ; Michie PT
    Biol Psychol; 2012 Jan; 89(1):220-31. PubMed ID: 22027085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nicotine on electroencephalographic (EEG) and behavioural measures of visual working memory in non-smokers during a dual-task paradigm.
    Fisher DJ; Knobelsdorf A; Jaworska N; Daniels R; Knott VJ
    Pharmacol Biochem Behav; 2013 Jan; 103(3):494-500. PubMed ID: 23026057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural effects of acute nicotinic treatment on visual spatial attention in non-smokers.
    Shah D; Impey D; Chique-Alfonzo M; Fisher D; Lorenzo-López L; Knott V
    Pharmacol Biochem Behav; 2011 Dec; 100(2):228-36. PubMed ID: 21889951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The N2 ERP component as an index of impaired cognitive control in smokers.
    Buzzell GA; Fedota JR; Roberts DM; McDonald CG
    Neurosci Lett; 2014 Mar; 563():61-5. PubMed ID: 24486891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural mechanisms underlying trait impulsivity in non-clinical adults: stop-signal performance and event-related potentials.
    Dimoska A; Johnstone SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):443-54. PubMed ID: 17175083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nicotine on visuo-spatial selective attention as indexed by event-related potentials.
    Meinke A; Thiel CM; Fink GR
    Neuroscience; 2006 Aug; 141(1):201-12. PubMed ID: 16713104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia.
    Fisher DJ; Grant B; Smith DM; Borracci G; Labelle A; Knott VJ
    Psychiatry Res; 2012 Apr; 196(2-3):181-7. PubMed ID: 22425471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural effects of nicotine during auditory selective attention in smokers: an event-related potential study.
    Knott V; Blais C; Scherling C; Camarda J; Millar A; Fisher D; McIntosh J
    Neuropsychobiology; 2006; 53(3):115-26. PubMed ID: 16601362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.